IL6 and renal cell carcinoma: It is tempting to speculate that a similar mechanism may operate in renal cancer whereby the production of interleukin-1 by tumor-infiltrating monocytes may not only stimulate RCC cells to sustain an inflammatory microenvironment but also induce epithelial memory impacting on tumor progression through IL6 production.